The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
2688 results found
In conjunction with the Australian Clinical Trials Alliance, we developed the clinical trials competencies to be used in the development of detailed curricula and training courses by universities, Colleges and other registered training organisations*.
Part 2 of the Freedom of Information Act 1982 establishes the Information Publication Scheme (IPS) for Australian Government agencies subject to the Act. The IPS requires agencies to publish a broad range of information on their websites and to list certain documents that are not available online with detail of how they can be accessed.
The NHMRC and ARC Statement on Open Researcher and Contributor ID explains NHMRC's position on the ORCID researcher identifier.
When working with research that involves human embryos created by assisted reproductive technology (ART), it can be difficult to determine if a licence is required for training and quality assurance activities. The attached documents provide information and helpful links to help identify legislative requirements.
Leukaemias are difficult-to-treat blood cancers, which are common among both young and older people. In Australia in 2023, around 20,000 people were diagnosed with a blood cancer and blood cancers accounted for an estimated 38% of all cancer cases among the 0–19 year-old age group. Over 5,000 Australians die each year from blood cancers.1 NHMRC-funded researchers at WEHI have made revolutionary breakthroughs in our understanding of leukaemia biology, leading to the development of a new type of anti-cancer drug, venetoclax, that has significantly improved treatment for leukaemia patients.
Australia’s capacity for health and medical research translation is receiving a $3.7 million funding boost to help improve public health policy and service delivery.
Knowledge gained through research underpins improvements in Australia's health and medical services. This research can be fundamental or can be applied, directly addressing clinical problems, public policy, quality of life and environmental health issues or the provision of health services.
National Science Week is an annual celebration that promotes and encourages interest in STEMM and acknowledges the contributions of Australian scientists to our ever-growing world of knowledge.In this Speaking of Science webinar held during National Science Week (10 August – 18 August 2024), we were joined by the inspirational cell biologist and Laboratory Head at WEHI and the University of Melbourne, Professor Shalin Naik. Professor Naik is well versed in communicating complex science concepts across to the public in more simple ways where possible, and without belittling the important work that underlies it. In this webinar, he did just that!
NHMRC, guided by its Principal Committee Indigenous Caucus (PCIC), conducted a national consultation on the Indigenous Research Excellence Criteria (IREC) to consider how the criteria are working in practice and whether improvements are needed.
The major national health issues outlined below are NHMRC's health priorities for the 2024–2027 triennium.
Members of NHMRC’s Dietary Guidelines Governance Committee (the Governance Committee) have been appointed to consider possible conflicts of interest and potential bias across the revision of the 2013 Australian Dietary Guidelines.
This section provides definitions of terms used in the Staying healthy guidelines.
This section explains infections, their causes, and how you can break the chain of infection.
There is no single solution to infection prevention and control - a collaborative approach is required. NHMRC’s guidelines outline strategies to consider across the healthcare system and early childhood education settings.